Evidence map›Paper›PMID 25978407›Full record

ArticlePloS one2015

Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study.

Adela Castelló, Miguel Martín, Amparo Ruiz, Ana M Casas, Jose M Baena-Cañada, Virginia Lope, Silvia Antolín, Pedro Sánchez, Manuel Ramos, Antonio Antón and 15 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Current status and challenges of breast cancer prevention~DNA methylation would lead to groundbreaking progress in breast cancer prevention~.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2023
    Review
  13. Article
  14. The Benefits of Exercise in Breast Cancer.Arquivos brasileiros de cardiologia · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. PARP Inhibition and Beyond in BRCA-Associated Breast Cancer in Women: A State-Of-The-Art Summary of Preclinical Research on Risk Reduction and Clinical Benefits.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 17 institutions in 1 country.

Adela CastellóCancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain.
Miguel MartínMedical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain.
Amparo RuizMedical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain.
Ana M CasasMedical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain.
Jose M Baena-CañadaMedical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain.
Virginia LopeCancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain.
Silvia AntolínMedical Oncology Unit, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Pedro SánchezMedical Oncology Unit, Complejo Hospitalario de Jaén, Jaén, Spain.
Manuel RamosMedical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain.
Antonio AntónMedical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Montserrat MuñozMedical Oncology Unit, Hospital Clinic I Provincial, Barcelona, Spain.
Begoña BermejoMedical Oncology Unit, Hospital Clínico, Valencia, Spain.
Ana De Juan-FerréMedical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain.
Carlos JaraMedical Oncology Unit, Fundación Hospitalaria de Alcorcón, Alcorcón, Spain.
José I ChacónMedical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain.
María A JimenoStart-up Unit, Spanish Breast Cancer Research Group (GEICAM) Headquarters, San Sebastián De Los Reyes, Madrid, Spain.
Petra RosadoMedical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain.
Elena DíazMedical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain.
Vicente GuillemMedical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain.
Ana LluchMedical Oncology Unit, Hospital Clínico, Valencia, Spain.
Eva CarrascoMedical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain.
Beatriz Pérez-GómezCancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain.
Jesús VioqueConsortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Epidemiology Department, Universidad Miguel Hernandez, Sant Joan d'Alacant, Spain.
Marina PollánCancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain.
EpiGEICAM Researchers
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESFundación Instituto Valenciano de Oncología · ESHospital Clínico Universitario de Valencia · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario Virgen del Rocío · ESInstituto de Salud Carlos III · ESMarqués de Valdecilla University Hospital · ESCentro Oncológico de Galicia · ESComplejo Hospitalario de Jaén · ESComplexo Hospitalario Universitario A Coruña · ESGEICAM – Spanish Breast Cancer Group · ESHospital Clínic de Barcelona · ESHospital Universitario Fundación Alcorcón · ESHospital Universitario Miguel Servet · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Puerta del Mar · ESHospital Virgen de la Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccording to the "World Cancer Research Fund" and the "American Institute of Cancer Research" (WCRF/AICR) one in four cancer cases could be prevented through a healthy diet, weight control and physical activity.

objectiveTo explore the association between the WCRF/AICR recommendations and risk of breast cancer.

methodsDuring the period 2006 to 2011 we recruited 973 incident cases of breast cancer and 973 controls from 17 Spanish Regions. We constructed a score based on 9 of the WCRF/AICR recommendations for cancer prevention:: 1)Maintain adequate body weight; 2)Be physically active; 3)Limit the intake of high density foods; 4)Eat mostly plant foods; 5)Limit the intake of animal foods; 6)Limit alcohol intake; 7)Limit salt and salt preserved food intake; 8)Meet nutritional needs through diet; S1)Breastfeed infants exclusively up to 6 months. We explored its association with BC by menopausal status and by intrinsic tumor subtypes (ER+/PR+ & HER2-; HER2+; ER&PR-&HER2-) using conditional and multinomial logistic models respectively.

resultsOur results point to a linear association between the degree of noncompliance and breast cancer risk. Taking women who met 6 or more recommendations as reference, those meeting less than 3 showed a three-fold excess risk (OR=2.98(CI95%:1.59-5.59)), especially for postmenopausal women (OR=3.60(CI95%:1.24;10.47)) and ER+/PR+&HER2- (OR=3.60(CI95%:1.84;7.05)) and HER2+ (OR=4.23(CI95%:1.66;10.78)) tumors. Noncompliance of recommendations regarding the consumption of foods and drinks that promote weight gain in premenopausal women (OR=2.24(CI95%:1.18;4.28); p for interaction=0.014) and triple negative tumors (OR=2.93(CI95%:1.12-7.63)); the intake of plant foods in postmenopausal women (OR=2.35(CI95%:1.24;4.44)) and triple negative tumors (OR=3.48(CI95%:1.46-8.31)); and the alcohol consumption in ER+/PR+&HER2- tumors (OR=1.52 (CI95%:1.06-2.19)) showed the strongest associations.

conclusionBreast cancer prevention might be possible by following the "World Cancer Research Fund" and the "American Institute of Cancer Research" recommendations, even in settings like Spain, where a high percentage of women already comply with many of them.

Indexed as

Academies and InstitutesAdolescentAdultAgedBreast NeoplasmsCase-Control StudiesEnergy IntakeFeeding BehaviorFemaleHumansLife StyleMiddle AgedSpainUnited StatesYoung Adult

Identifiers

PMID25978407
PMCPMC4433351
OpenAlexW239721312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.